Abivax (ABVX) Net Margin: 2022-2025
Historic Net Margin for Abivax (ABVX) over the last 1 years, with Jun 2025 value amounting to 753.06%.
- Abivax's Net Margin rose 12581757.00% to 753.06% in Q2 2025 from the same period last year, while for Jun 2025 it was 1,163.94%, marking a year-over-year decrease of 62680.00%. This contributed to the annual value of -1,415.71% for FY2024, which is 178143.00% up from last year.
- According to the latest figures from Q2 2025, Abivax's Net Margin is 753.06%, which was down 32.89% from 1,122.13% recorded in Q1 2025.
- In the past 5 years, Abivax's Net Margin registered a high of 1,122.13% during Q1 2025, and its lowest value of -125,064.52% during Q2 2024.
- For the 3-year period, Abivax's Net Margin averaged around -20,374.15%, with its median value being 376.74% (2023).
- Per our database at Business Quant, Abivax's Net Margin tumbled by 40bps in 2024 and then surged by 12,581,757bps in 2025.
- Over the past 4 years, Abivax's Net Margin (Quarterly) stood at -1,408.70% in 2022, then soared by 140,912bps to 0.42% in 2023, then crashed by 40bps to 0.02% in 2024, then skyrocketed by 12,581,757bps to 753.06% in 2025.
- Its Net Margin was 753.06% in Q2 2025, compared to 1,122.13% in Q1 2025 and 0.02% in Q4 2024.